Electronic Data Systems (NYSE:EDS) opened today at $28.27. So far, the stock has hit a low of $28.17 and a high of $28.39. As of 10:13 this morning, EDS was trading at $28.34, up $0.07 (0.25%) on extremely heavy volume.
After hitting a one year low of $22.42 on July 18, 2006, the stock snaked up 26.7% to a 52-week high of $28.40 yesterday at 2:59 in the afternoon. Electronic Data Systems reported earnings last week and investors seem to like the direction the company is headed. The technicals for EDS have been strongly improving lately and S&P gives the company a 4 STAR (out of 5) buy rating with a current 12-Month target price of $32.
For a neutral hedged play on EDS, I would consider a June covered call at the $27.50 level. There is even a small dividend on the stock with a 0.7% annual yield.
Vic Schiller is an analyst on the move at Investors Observer. (Free Subscription)
DISCLOSURE NOTE: Mr. Schiller owns and/or controls diversified portfolios of long and short stock and option positions that may include holdings in companies he writes about.
Last updated: November 23, 2009: 11:51 AM
Hot Stocks
DailyFinance Headlines
- Upset about deceptive 'free' credit reports? FTC wants to hear from you
- Wikipedia volunteers dropping like flies
- Jamie Dimon for Treasury chief? Or will Geithner be Obama's Rumsfeld?
- Microsoft, Murdoch talk team-up to freeze Google out of online news
- Stocks in the news: Hewlett-Packard, Cadbury, Ciena, LDK Solar
Latest from BloggingBuyouts
- Skype soap opera ends as founders set to regain stake ahead of $2B sale
- Big LBOs are teetering, but Wall Street still planning record bonuses
TheFlyOnTheWall.com Headlines
- GM asks European governments to help pay for restructuring, AP reports
- Peet's Coffee downgraded to Neutral from Outperform at Cowen
- TheFly's Rumor Round-Up
- Brynwood Partners IV acquires Balance Bar from Kraft Foods, Dow Jones reports
- Financial Federal spikes on acquisition news
BioHealth Investor Headlines
- Stem Cell Study Starts in PMD (STEM)
- Cephalon (CEPH) Hammered On Harsh Trial News
- Value Stocks in Drugs & Biotech (AMGN, BIIB, CBST, CEPH, PDLI)
- Activist Going Back After Biogen Idec (BIIB, CELG, GILD, GENZ, AMGN)
- Share Offerings Weigh on BioHealth Shares
WalletPop Headlines
- Go for Less: Cruising on the new Carnival Dream
- Let us now pray: Church mortgage delinquencies on the rise
- Oprah retiring? Not likely
- Can you trust T-Mobile's Sidekick?
- Vending machines invoke new technology to attract shoppers
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Money
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Checking Account
- Savings Account
- Credit Cards
- Credit Report
- DJIA
- Identity Theft
- Debt Management
- Loans
- Auto Loan
- Personal Loans
- Mortgages
- Refinancing
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Dow Jones Industrial Average
- AMT
- Car Insurance
- Common Tax Filing Mistakes
- Credit Score Calculator
- Crude Oil Prices
- DailyFinance
- Deals
- ETF Investing
- Financial Crisis
- GOOG
- Health Insurance
- Historical Stock Prices
- Home Insurance
- Income Tax
- Investing For Retirement
- Life Insurance
- Madoff
- Online Tax Filing
- Pig Flu
- Recession
- Resume Builder
- Stock Brokers
- Stock Ticker
- Tax Advice
- Tax Audit
- Tax Credit
- Tax Deductions
- Tax Forms
- Tech News
WalletPop Headlines
Other Weblogs Inc. Network blogs you might be interested in:










